Baxter acquires Baxa for $380 million

08/31/2011 | Clinica (subscription required)

Englewood, Colo.-based Baxa, a developer of the InFuse syringe infuser among other pharmacy devices and automation technology products, has been acquired by Baxter for $380 million. The buyout will allow Baxter to expand its product portfolio in intravenous nutrition and fluid delivery.

View Full Article in:

Clinica (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD